Keywords
How to Cite
Abstract
Today, type 2 diabetes mellitus (T2DM) and sarcopenia (SA) are becoming increasingly common diseases. The question of whether the onset of type 2 diabetes increases the risk of developing CA or vice versa has long been under study. Both conditions are associated with negative changes in the state of skeletal muscles, which in turn can lead to impaired physical function, decreased quality of life, and increased mortality risk. Improper nutrition can exacerbate both type 2 diabetes and SA. T2DM and SA are linked by a vicious circle of events that intensify and worsen each other. Muscle insulin resistance appears to be a pathophysiological link between type 2 diabetes and CA. [1].
References
1. Lopez-Pedrosa JM, Camprubi-Robles M, Guzman-Rolo G, Lopez-Gonzalez A, Garcia-Almeida JM, Sanz-Paris A, Rueda R. The Vicious Cycle of Type 2 Diabetes Mellitus and Skeletal Muscle Atrophy: Clinical, Biochemical, and Nutritional Bases. //Nutrients. 2024 Jan 4;16(1):172. doi: 10.3390/nu16010172.
2. Scott, D.; de Courten, B.; Ebeling, P.R. Sarcopenia: A potential cause and consequence of type 2 diabetes in Australia’s ageing population? // Med. J. Aust. 2016, 205, 329–333.
3. Park, S.W.; Goodpaster, B.H.; Lee, J.S.; Kuller, L.H.; Boudreau, R.; de Rekeneire, N.; Harris, T.B.; Kritchevsky, S.; Tylavsky, F.A.; Nevitt, M.; et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. //Diabetes Care 2009, 32, 1993–1997.
4. Anagnostis, P.; Gkekas, N.K.; Achilla, C.; Pananastasiou, G.; Taouxidou, P.; Mitsiou, M.; Kenanidis, E.; Potoupnis, M.; Tsiridis, E.; Goulis, D.G. Type 2 diabetes mllitus is associated with increased risk of sarcopenia: A systematic review and meta-analysis. // Calcif. Tissue Int. 2020, 107, 453–463.
5. Mori, H.; Kuroda, A.; Yoshida, S.; Yasuda, T.; Umayahara, Y.; Shimizu, S.; Ryomoto, K.; Yoshiuchi, K.; Yamamoto, T.; Matsuoka, T.A.; et al. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study. // J. Diabetes Investig. 2021, 12, 1050–1059.
6. Pechmann, L.M.; Jonasson, T.H.; Canossa, V.S.; Trierweiler, H.; Kisielewicz, G.; Petterle, R.R.; Moreira, C.A.; Borba, V.Z.C. Sarcopenia in type 2 diabetes mellitus: A cross-sectional observational study. //Int. J. Endocrinol. 2020, 2020, 7841390
7. Perry, B.D.; Caldow, M.K.; Brennan-Speranza, T.C.; Sbaraglia, M.; Jerums, G.; Garnham, A.; Wong, C.; Levinger, P.; Asrar Ul Haq, M.; Hare, D.L.; et al. Muscle atrophy in patients with type 2 diabetes mellitus: Roles of inflammatory pathways, physical activity and exercise. //Exerc. Immunol. Rev. 2016, 22, 94–109
8. DeFronzo, R.A.; Ferrannini, E.; Groop, L.; Henry, R.R.; Herman, W.H.; Holst, J.J.; Hu, F.B.; Kahn, C.R.; Raz, I.; Shulman, G.I.; et al. Type 2 diabetes mellitus. //Nat. Rev. Dis. Primers 2015, 1, 15019.
9. Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martin, C. Pathophysiology of type 2 diabetes mellitus. //Int. J. Mol. Sci. 2020, 21, 6275
10. Powers, S.K.; Lynch, G.S.; Murphy, K.T.; Reid, M.B.; Zijdewind, I. Disease-induced skeletal muscle atrophy and fatigue. //Med. Sci. Sports Exerc. 2016, 48, 2307–2319.
11. Argiles, J.M.; Campos, N.; Lopez-Pedrosa, J.M.; Rueda, R.; Rodriguez-Manas, L. Skeletal muscle regulates metabolism via interorgan crosstalk: Roles in health and disease. //J. Am. Med. Dir. Assoc. 2016, 17, 789–796.
12. Shen, Y.; Li, M.; Wang, K.; Qi, G.; Liu, H.; Wang, W.; Ji, Y.; Chang, M.; Deng, C.; Xu, F.; et al. Diabetic muscular atrophy: Molecular mechanisms and promising therapies. // Front. Endocrinol. 2022, 13, 917113.
13. Lee DH, Keum N, Hu FB, et al. Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. //BMJ. 2018;362:k2575. doi:10.1136/bmj.k2575
14. Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. // Int J Mol Sci. 2020;21(2):494. doi:10.3390/ijms21020494